TEVA On Other Exchanges
Symbol
Exchange
New York
Mexico
Frankfurt
text size: T | T
Back to Snapshot
Company Description

Contact Info

5 Basel Street

PO Box 3190

Petach Tikva, 49131

Israel

Phone: 972 3 926 7267

Fax: 972 3 923 4050

which incorporates the two companies’ OTC businesses outside of North America. Others The company sells third-party products for which it acts as distributor, mostly in Israel and Hungary, as well as sells medical products and other miscellaneous items. Regulation United States All pharmaceutical manufacturers selling products in the United States are subject to extensive regulation by the United States federal government, principally by the FDA and the Drug Enforcement Administration, and, to a lesser extent, by state and local governments. Its facilities are periodically inspected by the FDA, which has extensive enforcement powers over the activities of pharmaceutical manufacturers. Significant Events In March 2016, Teva Pharmaceutical Industries Ltd. and Takeda Pharmaceutical Company Limited announced the establishment of Teva Takeda Yakuhin Ltd. In April 2016, Takeda Pharmaceutical Company Limited and Teva Pharmaceutical Industries Ltd. announced the establishment of Teva Takeda Yakuhin Ltd. Location: Ohara-ichiba, Koka-cho, Koka City, Shiga Pref. Scope of business: Development, manufacturing, sales and marketing of pharmaceutical products. In September 2016, Teva (Israel) entered collaboration with the technology company Intel (US), to develop a wearable device to monitor the functioning and movement of patients with Huntington's disease. Teva plans to test the technology for the first time in a sub-study of the ongoing Phase II Open-Pride HD trial. In September 2016, Teva Pharmaceutical Industries Ltd. and Regeneron Pharmaceuticals, Inc. announced a global1 agreement to develop and commercialize fasinumab, Regeneron’s investigational NGF antibody in Phase 3 clinical development for osteoarthritis pain and in Phase 2 development for chronic low back pain. History Teva Pharmaceutical Industries Limited was founded in 1901. The company was incorporated in Israel in 1944.

 

The information and data displayed in this profile are created and managed by S&P Global Market Intelligence, a division of S&P Global. Bloomberg.com does not create or control the content.

Stock Quotes

Market data is delayed at least 15 minutes.

Company Lookup

TEVA Competitors

Market data is delayed at least 15 minutes.

Company Last Change
No competitor information is available for TEVA.
View Industry Companies
 

Industry Analysis

TEVA

Industry Average

Valuation TEVA Industry Range
Price/Earnings 30.6x
Price/Sales 2.2x
Price/Book 1.6x
Price/Cash Flow 31.3x
TEV/Sales 1.2x
 | 

Sponsored Financial Commentaries

Sponsored Links

Request Profile Update

Only a company representative may request an update for the company profile. Documentation will be required.

To contact TEVA PHARMACEUTICAL-SP ADR, please visit www.tevapharm.com. Company data is provided by S&P Global Market Intelligence. Please use this form to report any data issues.

Please enter your information in the following field(s):
Update Needed*

All data changes require verification from public sources. Please include the correct value or values and a source where we can verify.

Your requested update has been submitted

Our data partners will research the update request and update the information on this page if necessary. Research and follow-up could take several weeks. If you have questions, you can contact them at bwwebmaster@businessweek.com.